Skip to main content

BC Cancer – Surrey

If you are interested in more information about a particular trial, please talk with your treating physician first, and they may contact this centre for further information if necessary.

Tumour Group / Site Trial Title Opening Date

A Randomized Trial of Regional Radiotherapy In Biomarker Low Risk Node Positive Breast Cancer CCTG MA.39

Sept 2019
A Phase III, Randomized, Double-Blind, Placebo-Controlled Study Evaluating The Efficacy And Safety Of GDC-0077 Plus Palbociclib And Fulvestrant Versus Placebo Plus Palbociclib And Fulvestrant In Patients With PIK3CA-Mutant, Hormone Receptor-Positive, Her2-Negative Locally Advanced Or Metastatic Breast Cancer (WO41554) PIK3
July 2020
A Randomized Phase II Trial Comparing Biomarker Directed Therapy Versus Clinician's Choice of Enzalutamide or Docetaxel in Patients with Advanced Prostate Cancer Post Abiraterone
EA5163/S1709 INSIGNA: A Randomized, Phase III Study of First line Immunotherapy alone or in Combination with Chemotherapy in Induction / Maintenance or Post-progression in Advanced Non-squamous Non-Small Cell Lung Cancer (NSCLC) with Immunobiomarker SIGNature-driven Analysis  CCTG BRC.7
July 2020
LymphomaBiology of Lymphoid Cancer
Lymphoid Study
Jan 2014

A Randomized Phase III Study of Duration of Anti-PD-1 Therapy in Metastatic Melanoma CCTG ME.13

July 2017

Stereotactic Radiotherapy for Oligo-Progressive Metastatic Cancers (The STOP Trial): A Randomized Phase II Trial
May 2020

SOURCE: BC Cancer – Surrey ( )
Page printed: . Unofficial document if printed. Please refer to SOURCE for latest information.

Copyright © BC Cancer. All Rights Reserved.

    Copyright © 2022 Provincial Health Services Authority